CDK clinical trial results, benefit, side effects and costs

Share :
Sorry, this item is currently unavailable.
Published: 26 Oct 2016
Views: 2589
Dr Pierfranco Conte - Instituto Oncologico Veneto, Padua, Italy

Dr Conte discusses clinical trial results of CDK 4/6 inhibitors in breast cancer, including their benefits, side effects and costs, at ESMO 2016

Supported by a grant from Pfizer Inc.